3,4-dihydroxyphenylacetic acid has been researched along with scopolamine hydrobromide in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (38.10) | 18.7374 |
| 1990's | 9 (42.86) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 1 (4.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maitre, L; Waldmeier, PC | 1 |
| Waldmeier, PC | 1 |
| Crow, TJ; Deakin, JF; Longden, A | 1 |
| De Natale, G; Desole, MS; Enrico, P; Esposito, G; Fresu, L; Miele, E; Miele, M | 2 |
| Grenhoff, J; Svensson, TH | 1 |
| Marsden, CA; Rivest, R | 2 |
| Hashimoto, T; Koda, H; Kuriyama, K | 1 |
| Carey, RJ | 1 |
| Memo, M; Missale, C; Spano, PF; Trivelli, L | 1 |
| Fernando, JC; Ho, IK; Hoskins, B | 1 |
| Buda, M; De Simoni, MG; Gonon, F; Pujol, JF | 1 |
| De Natale, G; Desole, MS; Enrico, P; Esposito, G; Fresu, L; Miele, M; Migheli, R | 1 |
| Chai, BL; Meltzer, HY; Thompson, PA; Yamamoto, BK | 1 |
| Iino, T; Katsura, M; Kuriyama, K | 1 |
| Connick, JH; Gray, AM | 1 |
| Amoroso, S; Cassano, T; Castrignanò, S; Colaianna, M; Cuomo, V; Giustino, A; Steardo, L; Trabace, L | 1 |
| Del Arco, A; Mora, F; Segovia, G | 1 |
| Batista, TM; Bruno, Rde B; Cunha, GM; de Arruda, KG; Lima, JC; Lima, PF; Marques, TF; Santos, Nda S; Viana, GS; Vitor, HV | 1 |
| Chen, L; Huang, L; Huang, X; Jiang, J; Li, S; Qiu, Y; Tang, L | 1 |
21 other study(ies) available for 3,4-dihydroxyphenylacetic acid and scopolamine hydrobromide
| Article | Year |
|---|---|
Effects of baclofen on dopamine metabolism and interaction with neuroleptic effects.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aminobutyrates; Animals; Antipsychotic Agents; Baclofen; Benserazide; Carboxy-Lyases; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Drug Interactions; Female; Homovanillic Acid; Limbic System; Male; Methyltyrosines; Picrotoxin; Rats; Scopolamine | 1978 |
Analysis of the activation of dopamine metabolism by a serotonin uptake inhibitor.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Baclofen; Benzofurans; Corpus Striatum; Dopamine; Female; Haloperidol; Homovanillic Acid; Piperidines; Rats; Scopolamine; Serotonin Antagonists; Time Factors | 1979 |
The nucleus accumbens--possible site of antipsychotic action of neuroleptic drugs?
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benztropine; Chlorpromazine; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Fluphenazine; Homovanillic Acid; Humans; Male; Psychotic Disorders; Rats; Receptors, Dopamine; Scopolamine; Tegmentum Mesencephali; Thioridazine; Tranquilizing Agents | 1977 |
Effects of cortical ablation on apomorphine- and scopolamine-induced changes in dopamine turnover and ascorbic acid catabolism in the rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Ascorbic Acid; Cerebral Cortex; Corpus Striatum; Dopamine; Glutamates; Glutamic Acid; Male; Rats; Rats, Inbred Strains; Scopolamine | 1992 |
Nicotinic and muscarinic components of rat brain dopamine synthesis stimulation induced by physostigmine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Dopamine; Male; Mecamylamine; Muscarine; Nicotine; Physostigmine; Rats; Rats, Sprague-Dawley; Scopolamine | 1992 |
Muscarinic antagonists attenuate neurotensin-stimulated accumbens and striatal dopamine metabolism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Atropine; Corpus Striatum; Dopamine; Electric Stimulation; Extracellular Space; Haloperidol; Male; Neurotensin; Nucleus Accumbens; Parasympatholytics; Rats; Rats, Inbred Strains; Scopolamine | 1992 |
Muscarinic antagonists attenuate the increase in accumbens and striatum dopamine metabolism produced by clozapine but not by haloperidol.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Atropine; Clozapine; Corpus Striatum; Dopamine; Electric Stimulation; Extracellular Space; Haloperidol; Male; Nucleus Accumbens; Parasympatholytics; Rats; Rats, Inbred Strains; Scopolamine | 1991 |
Further investigations into the relationship between the dopaminergic system, ascorbic acid and uric acid in the rat striatum.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Ascorbic Acid; Body Temperature; Corpus Striatum; Dehydroascorbic Acid; Dopamine; Male; Motor Activity; Oxidation-Reduction; Pilocarpine; Rats; Rats, Inbred Strains; Scopolamine; Stereotyped Behavior; Uric Acid | 1991 |
Muscarinic receptor-mediated regulation of OM-853-enhanced dopamine release in striatum of rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alkaloids; Animals; Apomorphine; Atropine; Carbachol; Corpus Striatum; Dopamine; Homovanillic Acid; In Vitro Techniques; Male; Quinuclidinyl Benzilate; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Scopolamine; Vinca Alkaloids | 1989 |
Relationship of limbic dopamine levels to amphetamine- and anticholinergic-induced hyperactivity in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dextroamphetamine; Dopamine; Hydroxydopamines; Limbic System; Male; Motor Activity; Nucleus Accumbens; Olfactory Bulb; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Scopolamine | 1986 |
Acute scopolamine treatment decreases dopamine metabolism in rat hippocampus and frontal cortex.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Avoidance Learning; Cerebral Cortex; Dopamine; Hippocampus; Homovanillic Acid; Male; Rats; Rats, Inbred Strains; Scopolamine | 1988 |
The role of dopamine in behavioral supersensitivity to muscarinic antagonists following cholinesterase inhibition.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Atropine; Behavior, Animal; Cholinesterase Inhibitors; Dopamine; Homovanillic Acid; Isoflurophate; Male; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Scopolamine | 1986 |
Cholinergic control of catechol metabolism in the rat locus coeruleus as studied by in vivo voltammetry.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Catechols; Electrochemistry; Locus Coeruleus; Oxotremorine; Parasympathetic Nervous System; Rats; Rats, Inbred Strains; Scopolamine; Tyrosine 3-Monooxygenase | 1983 |
Cortical ablation and drug-induced changes in striatal ascorbic acid oxidation and behavior in the rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Ascorbic Acid; Behavior, Animal; Cerebral Cortex; Dehydroascorbic Acid; Dopamine; Glutamic Acid; Male; Motor Activity; Neostriatum; Oxidation-Reduction; Rats; Rats, Wistar; Scopolamine; Stereotyped Behavior; Synaptosomes | 1995 |
Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biological Transport; Clozapine; Corpus Striatum; Dopamine; Haloperidol; Homovanillic Acid; Male; Microdialysis; Nucleus Accumbens; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Scopolamine; Thioridazine | 1994 |
Effect of vinconate on the extracellular levels of dopamine and its metabolites in the rat striatum: microdialysis studies.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Male; Muscarinic Antagonists; Rats; Rats, Wistar; Scopolamine; Vinca Alkaloids | 1995 |
Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Carbachol; Cardiotonic Agents; Chromatography, High Pressure Liquid; Clozapine; Corpus Striatum; Dopamine; Drug Interactions; Haloperidol; Male; Microdialysis; Muscarinic Antagonists; Nucleus Accumbens; Rats; Rats, Wistar; Scopolamine | 1998 |
Neurochemical and neurobehavioral effects of ganstigmine (CHF2819), a novel acetylcholinesterase inhibitor, in rat prefrontal cortex: an in vivo study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Administration, Oral; Alkaloids; Analysis of Variance; Animals; Carbamates; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Dopamine; Exploratory Behavior; Extracellular Space; Homovanillic Acid; Male; Memory; Norepinephrine; Prefrontal Cortex; Rats; Rats, Wistar; Scopolamine; Serotonin | 2007 |
Blockade of NMDA receptors in the prefrontal cortex increases dopamine and acetylcholine release in the nucleus accumbens and motor activity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cholinergic Antagonists; Dopamine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Flupenthixol; Glutamic Acid; Homovanillic Acid; Injections, Intraventricular; Male; Mecamylamine; Microinjections; Motor Activity; Muscarinic Antagonists; N-Methylaspartate; Nicotinic Antagonists; Nucleus Accumbens; Piperazines; Prefrontal Cortex; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate; Scopolamine | 2008 |
Pentoxifylline treatment improves neurological and neurochemical deficits in rats subjected to transient brain ischemia.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Avoidance Learning; Brain; Brain Ischemia; Cognition; Dopamine; Exploratory Behavior; Grooming; Male; Maze Learning; Memory; Motor Activity; Neurons; Neuroprotective Agents; Pentoxifylline; Rats; Rats, Wistar; Scopolamine | 2009 |
5-HT(1A) receptor antagonist improves behavior performance of delirium rats through inhibiting PI3K/Akt/mTOR activation-induced NLRP3 activity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Basolateral Nuclear Complex; Emergence Delirium; Gene Expression Regulation; Hippocampus; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Injections, Intraventricular; Interleukin-1beta; Male; Maze Learning; NLR Family, Pyrin Domain-Containing 3 Protein; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Piperazines; Proto-Oncogene Proteins c-akt; Pyridines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Scopolamine; Serotonin; Serotonin Antagonists; Signal Transduction; Stereotaxic Techniques; TOR Serine-Threonine Kinases | 2016 |